Supporting the

Neuroendocrine Cancer Community

Review of Molecular Radiotherapy in the UK

Dec 14, 2021

This document presents a review of the present state for the provision of molecular radiotherapy services across the UK, concentrating on unequal provision across the four nations and proposals as to how these issues can be addressed to ensure equity of access to molecular radiotherapy services.

This review was undertaken by a task and finish group set up by four main stake holders:

  • British Nuclear Medicine Society
  • Institute for Physics and Engineering in Medicine
  • Royal College of Physicians
  • The Royal College of Radiologists.

CLICK HERE TO READ THE FULL DOCUMENT.